RXQ Compounding LLC recalls DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens,
Recalled August 14, 2019 · FDA recall D-1646-2019 · RXQ Compounding
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
Nationwide USA
Description
Lack of Assurance of Sterility
Product
DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89
Manufacturer(s)
RXQ Compounding LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →